EUVIMEDEUVIMED entdecken
Crossref

Acute myeloid leukemia with 4q12 rearrangements involving CHIC2 : “pitfalls” in fluorescence in situ hybridization diagnosis of PDGFRA rearrangements

Long Chen iD, Hong Zhang, Sasa Chai, Shaobin Yang, Jingya Yao, Xiaoju Hou, Xin Tian, Enbin Liu, Yani Lin iD, Kun Ru

American Journal of Clinical Pathology · 04.08.2026 · 166 (2)

DOI: 10.1093/ajcp/aqag084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, online erschienen am 05.08.2026. Verfasst von Long Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sino-US Diagnostics Lab, Tianjin Enterprise Key Laboratory of AI-aided Hematopathology Diagnosis, Tianjin, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Receptor, Platelet-Derived Growth Factor alpha, Chromosomes, Human, Pair 4. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Key Research and Development Program of Tianjin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Chromosome 4q12 rearrangements are recurrent in hematologic malignancies, most frequently involving PDGFRA. Fluorescence in situ hybridization (FISH) is routinely used for detecting 4q12 rearrangements. This study aimed to clarify 4q12 rearrangements misdiagnosed by FISH and explore the transcriptomic profile of acute myeloid leukemia (AML) with CHIC2 rearrangements.

Methods

Fluorescence in situ hybridization with a PDGFRA/CHIC2/FIP1L1 probe set detected 4q12 rearrangements. RNA sequencing (RNA-seq) characterized fusion transcripts and compared transcriptomic profiles between CHIC2-rearranged AML and NPM1-mutated controls, identifying differentially expressed genes and enriched pathways. Previously reported PDGFRA-independent 4q12 cases were reviewed.

Results

RNA sequencing of 2 AML cases with FISH signals suggestive of PDGFRA rearrangement identified CHIC2 fusions instead: a novel CDK6::CHIC2 and a known ETV6::CHIC2. Integrating our cases with a systematic literature review, we identified 41 hematologic neoplasms with PDGFRA-independent 4q12 rearrangements, of which 38 (92.7%) were AML. The 4q12 breakpoints most frequently involved CHIC2 (27 cases, 65.9%), followed by GSX2, SCFD2, and intergenic regions. Among 15 cases assessed by both FISH and molecular methods, FISH misclassified 9 (60.0%; 9/15) as PDGFRA rearranged; subsequent molecular testing revealed rearrangements of genes adjacent to PDGFRA (eg, CHIC2, GSX2) or intergenic regions. Transcriptomic profiling of CHIC2-rearranged AML revealed a distinct expression signature with 492 differentially expressed genes, including PDGFRA upregulation. Pathway analysis showed significant enrichment for cytokine-cytokine receptor interaction and JAK-STAT signaling (false discovery rate <0.05).

Conclusions

Molecular methods such as RNA-seq are effective for resolving cryptic 4q12 rearrangements in cases where FISH falsely suggests PDGFRA involvement. The distinct transcriptional profile of CHIC2-rearranged AML suggests dysregulated cytokine signaling and JAK-STAT activity in its pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteReceptor, Platelet-Derived Growth Factor alphaChromosomes, Human, Pair 4HumansIn Situ Hybridization, FluorescenceGene RearrangementNucleophosminFemaleMaleMiddle AgedAdultAged

Stichwörter der Autor:innen

CHIC2PDGFRAAMLFISHRNA-seq

Substanzen

Receptor, Platelet-Derived Growth Factor alphaNucleophosminNPM1 protein, human

Autor:innen und Institutionen

  • Sino-US Diagnostics Lab, Tianjin Enterprise Key Laboratory of AI-aided Hematopathology Diagnosis, Tianjin, China.
  • Department of Pathology and Lab Medicine, Shandong Cancer Hospital, Jinan, Shandong, China.

ORCID-Profile: Long Chen, Yani Lin

Förderung

  • Key Research and Development Program of Tianjin

Zitieren

APA

Chen, L., Zhang, H., Chai, S., Yang, S., Yao, J., Hou, X., Tian, X., Liu, E., Lin, Y., & Ru, K. (2026). Acute myeloid leukemia with 4q12 rearrangements involving CHIC2 : “pitfalls” in fluorescence in situ hybridization diagnosis of PDGFRA rearrangements. American Journal of Clinical Pathology, 166(2). https://doi.org/10.1093/ajcp/aqag084

Vancouver

Chen L, Zhang H, Chai S, Yang S, Yao J, Hou X, et al. Acute myeloid leukemia with 4q12 rearrangements involving CHIC2 : “pitfalls” in fluorescence in situ hybridization diagnosis of PDGFRA rearrangements. American Journal of Clinical Pathology. 2026;166(2). doi:10.1093/ajcp/aqag084

BibTeX
@article{Chen2026,
  author = {Chen, Long and Zhang, Hong and Chai, Sasa and Yang, Shaobin and Yao, Jingya and Hou, Xiaoju and Tian, Xin and Liu, Enbin and Lin, Yani and Ru, Kun},
  title = {Acute myeloid leukemia with 4q12 rearrangements involving CHIC2 : “pitfalls” in fluorescence in situ hybridization diagnosis of PDGFRA rearrangements},
  journal = {American Journal of Clinical Pathology},
  year = {2026},
  volume = {166},
  number = {2},
  doi = {10.1093/ajcp/aqag084}
}
Kostenlos starten →